These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 30615804)
21. Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease. Tetzloff KA; Graff-Radford J; Martin PR; Tosakulwong N; Machulda MM; Duffy JR; Clark HM; Senjem ML; Schwarz CG; Spychalla AJ; Drubach DA; Jack CR; Lowe VJ; Josephs KA; Whitwell JL J Alzheimers Dis; 2018; 62(4):1713-1724. PubMed ID: 29614676 [TBL] [Abstract][Full Text] [Related]
22. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study. Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153 [TBL] [Abstract][Full Text] [Related]
23. α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies. van Steenoven I; Majbour NK; Vaikath NN; Berendse HW; van der Flier WM; van de Berg WDJ; Teunissen CE; Lemstra AW; El-Agnaf OMA Mov Disord; 2018 Nov; 33(11):1724-1733. PubMed ID: 30440090 [TBL] [Abstract][Full Text] [Related]
24. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102 [TBL] [Abstract][Full Text] [Related]
25. Smith R; Schöll M; Londos E; Ohlsson T; Hansson O Sci Rep; 2018 Mar; 8(1):4717. PubMed ID: 29549278 [TBL] [Abstract][Full Text] [Related]
26. The association between tau PET and retrospective cortical thinning in clinically normal elderly. LaPoint MR; Chhatwal JP; Sepulcre J; Johnson KA; Sperling RA; Schultz AP Neuroimage; 2017 Aug; 157():612-622. PubMed ID: 28545932 [TBL] [Abstract][Full Text] [Related]
27. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Beyer MK; Larsen JP; Aarsland D Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706 [TBL] [Abstract][Full Text] [Related]
28. Tau in dementia with Lewy bodies. Chin KS; Churilov L; Doré V; Villemagne VL; Rowe CC; Yassi N; Watson R Aust N Z J Psychiatry; 2024 Feb; 58(2):175-182. PubMed ID: 37264610 [TBL] [Abstract][Full Text] [Related]
29. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease. Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874 [TBL] [Abstract][Full Text] [Related]
30. Cortical thinning in dementia with Lewy bodies and Parkinson disease dementia. Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP Aust N Z J Psychiatry; 2020 Jun; 54(6):633-643. PubMed ID: 31696728 [TBL] [Abstract][Full Text] [Related]
31. 18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome. Goodheart AE; Locascio JJ; Samore WR; Collins JA; Brickhouse M; Schultz A; Touroutoglou A; Johnson KA; Frosch MP; Growdon JH; Dickerson BC; Gomperts SN Brain; 2021 Feb; 144(1):266-277. PubMed ID: 33578418 [TBL] [Abstract][Full Text] [Related]
32. A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium. Oppedal K; Ferreira D; Cavallin L; Lemstra AW; Ten Kate M; Padovani A; Rektorova I; Bonanni L; Wahlund LO; Engedal K; Nobili F; Kramberger M; Taylor JP; Hort J; Snædal J; Blanc F; Walker Z; Antonini A; Westman E; Aarsland D; Alzheimers Dement; 2019 Mar; 15(3):400-409. PubMed ID: 30439333 [TBL] [Abstract][Full Text] [Related]
33. Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology. Silva-Rodríguez J; Labrador-Espinosa MA; Moscoso A; Schöll M; Mir P; Grothe MJ; Brain; 2023 Nov; 146(11):4520-4531. PubMed ID: 37284793 [TBL] [Abstract][Full Text] [Related]
34. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography. Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004 [TBL] [Abstract][Full Text] [Related]
35. Cortical metabolic and nigrostriatal abnormalities associated with clinical stage-specific dementia with Lewy bodies. Huang SH; Chang CC; Lui CC; Chen NC; Lee CC; Wang PW; Jiang CF Clin Nucl Med; 2015 Jan; 40(1):26-31. PubMed ID: 25426755 [TBL] [Abstract][Full Text] [Related]
36. Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies. Graff-Radford J; Boeve BF; Pedraza O; Ferman TJ; Przybelski S; Lesnick TG; Vemuri P; Senjem ML; Smith GE; Knopman DS; Lowe V; Jack CR; Petersen RC; Kantarci K Brain; 2012 Aug; 135(Pt 8):2470-7. PubMed ID: 22810436 [TBL] [Abstract][Full Text] [Related]